RESUMEN
Hospital in the Home (HITH) model of care was developed to support the COVID-19 response and the need to deliver care in new ways to ensure secondary care services were free to deliver care to the sickest patients and not be overwhelmed by the COVID-19 patients needing hospital-level care. Intermediate Care Services, led by nursing and allied health stepped up to the challenge and collaborated on the development of the HITH model of care with defined pathways. This provided hospital-level acute health services in the home that was a clinically safe alternative option to inpatient care. The establishment of HITH released bed capacity and resources and therefore prevented the need for expanding hospital inpatient capacity at a time where resources and staff were constrained. Care delivery was achieved by utilising both in-person visits and telehealth. Technology supported the care delivery which allowed patients, whanau (family) and clinicians to be connected.
Asunto(s)
COVID-19 , Telemedicina , COVID-19/enfermería , Humanos , SARS-CoV-2 , Modelos Organizacionales , Servicios de Atención a Domicilio Provisto por Hospital/organización & administración , Servicios de Atención de Salud a Domicilio , Vías ClínicasRESUMEN
The Hospital at Home (HaH) program has experienced accelerated growth in major Canadian provinces, driven in part by technological advancements and evolving patient needs during the COVID-19 pandemic. As an increasing number of hospitals pilot or implement these innovative programs, substantial resources have been allocated to support clinical teams. However, it is crucial to note that the vital roles played by clinical laboratories remain insufficiently acknowledged. This mini review aims to shed light on the diverse functions of clinical laboratories, spanning the preanalytical, analytical, and post-analytical phases within the HaH program context. Additionally, the review will explore recent advancements in clinical testing and the potential benefits of integrating new technologies into the HaH framework. Emphasizing the integral role of clinical laboratories, the discussion will address the current barriers hindering their active involvement, accompanied by proposed solutions. The capacity and efficiency of the HaH program hinge on sustained collaborative efforts from various teams, with clinical laboratories as crucial team players. Recognizing and addressing the specific challenges faced by clinical laboratories is essential for optimizing the overall performance and impact of the HaH initiative.
Asunto(s)
COVID-19 , Humanos , COVID-19/epidemiología , Canadá , SARS-CoV-2 , Pandemias , Laboratorios Clínicos , Servicios de Atención a Domicilio Provisto por Hospital/organización & administración , Pacientes InternosRESUMEN
PURPOSE: Hospital at home (HaH) program development, spurred by hospital congestion during the COVID-19 pandemic, is moving from a novel idea to a standard of inpatient practice. Understanding pharmacy's clinical role in the HaH patient care team is exceedingly important as programs across the country continue to develop, implement, and expand. The purpose of this study is to describe how clinical pharmacy services are currently provided for home hospital patients and to explain the vital role of pharmacists within the HaH care team. DESCRIPTION: A descriptive study was designed to evaluate pharmacy services provided for home hospital patients from January 1, 2023, to February 28, 2023. Prior to the study period, a focused group of pharmacists routinely active in HaH patient care met to define a standard process for documenting pharmacy services using an electronic documentation system (i-Vent) within the EHR. During the study period, a total of 221 patients were admitted to home hospital at either site representing 3,258 inpatient medication orders with 2,997 medication administrations. Pharmacists signed 903 progress notes and documented 561 interventions across all types. The top 3 pharmacy intervention types were drug administration change (37%), medication reconciliation (29%), and antimicrobial stewardship (15%). Each of the top 3 types were further evaluated by subtype. CONCLUSION: Documented pharmacy services encompassed a variety of intervention types. The overwhelming majority of patients admitted to the program received pharmacy consultative services, demonstrating how pivotal pharmacists are to the operational success of these programs and clinical care of HaH patients. More research is needed to expose pharmacy potential and facilitate growth for pharmacists practicing in HaH programs.
Asunto(s)
COVID-19 , Grupo de Atención al Paciente , Farmacéuticos , Servicio de Farmacia en Hospital , Rol Profesional , Humanos , Servicio de Farmacia en Hospital/organización & administración , Grupo de Atención al Paciente/organización & administración , COVID-19/epidemiología , Farmacéuticos/organización & administración , Servicios de Atención a Domicilio Provisto por Hospital/organización & administración , Masculino , Femenino , Conciliación de Medicamentos/organización & administración , Conciliación de Medicamentos/métodos , Anciano , Persona de Mediana EdadRESUMEN
BACKGROUND: The diffusion of innovation in healthcare is sluggish. Evidence-based care models and interventions take years to reach patients. We believe the healthcare community could deliver innovation to the bedside faster if it followed other sectors by employing an organisational framework for efficiently accomplishing work. Home hospital is an example of sluggish diffusion. This model provides hospital-level care in a patient's home instead of in a traditional hospital with equal or better outcomes. Home hospital uptake has steadily grown during the COVID-19 pandemic, yet barriers to launch remain for healthcare organisations, including access to expertise and implementation tools. The Home Hospital Early Adopters Accelerator was created to bring together a network of healthcare organisations to develop tools necessary for programme implementation. METHODS: The accelerator used the Agile framework known as Scrum to rapidly coordinate work across many different specialised skill sets and blend individuals who had no experience with one another into efficient teams. Its goal was to take 40 weeks to develop 20 'knowledge products',or tools critical to the development of a home hospital programme such as workflows, inclusion criteria and protocols. We conducted a mixed-methods evaluation of the accelerator's implementation, measuring teams' productivity and experience. RESULTS: 18 healthcare organisations participated in the accelerator to produce the expected 20 knowledge products in only 32 working weeks, a 20% reduction in time. Nearly all (97.4%) participants agreed or strongly agreed the Scrum teams worked well together, and 96.8% felt the teams produced a high-quality product. Participants consistently remarked that the Scrum team developed products much faster than their respective organisational teams. The accelerator was not a panacea: it was challenging for some participants to become familiar with the Scrum framework and some participants struggled with balancing participation in the Accelerator with their job duties. CONCLUSIONS: Implementation of an Agile-based accelerator that joined disparate healthcare organisations into teams equipped to create knowledge products for home hospitals proved both efficient and effective. We demonstrate that implementing an organisational framework to accomplish work is a valuable approach that may be transformative for the sector.
Asunto(s)
COVID-19 , Humanos , SARS-CoV-2 , Difusión de Innovaciones , Pandemias , Servicios de Atención de Salud a Domicilio/normas , Servicios de Atención a Domicilio Provisto por Hospital/organización & administraciónRESUMEN
Home hospital programs continue to grow across the United States. There are limited studies around the process of patient selection and successful acquisition from the emergency department. The article describes how an interdisciplinary team used quality improvement methodology to significantly increase the number of admissions directly from the emergency department to the Advanced Care at Home program.
Asunto(s)
Servicio de Urgencia en Hospital , Mejoramiento de la Calidad , Servicio de Urgencia en Hospital/estadística & datos numéricos , Servicio de Urgencia en Hospital/organización & administración , Humanos , Mejoramiento de la Calidad/organización & administración , Admisión del Paciente/estadística & datos numéricos , Servicios de Atención a Domicilio Provisto por Hospital/organización & administración , Estados Unidos , Grupo de Atención al Paciente/organización & administraciónRESUMEN
The Hospital at Home model, called Hospital-in-Home (HIH) in the Department of Veterans Affairs, delivers coordinated, high-value care aligned with older adult and caregiver preferences. Documenting implementation barriers and corresponding strategies to overcome them can address challenges to widespread adoption. To evaluate HIH implementation barriers and identify strategies to address them, we conducted interviews with 8 HIH staff at 4 hospitals between 2010 and 2013. We utilized qualitative directed content analysis guided by the Consolidated Framework for Implementation Research (CFIR) and mapped identified barriers to possible strategies using the CFIR-Expert Recommendations for Implementing Change (ERIC) Matching Tool. We identified 11 barriers spanning 5 CFIR domains. Three implementation strategies - identifying and preparing champions, conducting educational meetings, and capturing and sharing local knowledge - achieved high expert endorsement for each barrier. A mix of strategies targeting resources, organizational readiness and fit, and leadership engagement should be considered to support the sustainability and spread of HIH.
Asunto(s)
United States Department of Veterans Affairs , Humanos , Estados Unidos , United States Department of Veterans Affairs/organización & administración , Investigación Cualitativa , Masculino , Femenino , Servicios de Atención a Domicilio Provisto por Hospital/organización & administración , Persona de Mediana Edad , Anciano , Entrevistas como Asunto/métodos , Adulto , Servicios de Atención de Salud a Domicilio/normas , Servicios de Atención de Salud a Domicilio/tendenciasRESUMEN
INTRODUCTION: Immunotherapy has transformed the treatment paradigm of several cancers. Hospital-at-home (HAH) care is an innovative healthcare model in which treatments are delivered at home under the supervision of a hospital, which likely applies to cancer immunotherapy. For this home-care option, official treatment guidelines are still lacking. We therefore sought to create guidance and recommendations on how to administer immune response checkpoint inhibitor therapies and other monoclonal antibodies used in cancer treatment in the context of HAH setting. METHODS: A multidisciplinary group of healthcare professionals with expertise in managing cancer patients and prescribing immunotherapy in HAH settings was set up. RESULTS: Based on the survey results and working group discussions, six major components were identified: (1) existing HAH organization in France; (2) underlying framework; (3) flowchart; (4) patient pathway before, the day of, and after immunotherapy; (5) healthcare personnel training; (6) patient therapeutic education. The detailed specifications for each component are provided herein, along with an illustrative flowchart. The prerequisites for home administration of cancer immunotherapies are summarized in Table 1. DISCUSSION: This paper seeks to facilitate the implementation of cancer immunotherapy within HAH settings for the healthcare professionals concerned.
Asunto(s)
Servicios de Atención a Domicilio Provisto por Hospital/organización & administración , Inhibidores de Puntos de Control Inmunológico/administración & dosificación , Inmunoterapia , Neoplasias/terapia , Vías Clínicas , Francia , Personal de Salud/educación , Humanos , Educación del Paciente como Asunto , Selección de Paciente , Sociedades MédicasRESUMEN
CONTEXT: The administration of immune checkpoints inhibitors (ICIs) within hospitalization at home (HaH) organizations is an interesting alternative to conventional care. Three surveys were carried out to describe the different organizational models of French HaHs and criteria used by physicians in patient selection. METHODS: Three surveys were conducted between April 1 and August 31, 2020. The first one was addressed to all French HaHs, and the two others to public HaHs and oncologists treating patients with solid cancer in the Auvergne-Rhone-Alpes region. RESULTS: Overall, 54 French HaHs and 23 oncologists participated to the study. The health professionals involved in the patients' care were very heterogeneous, although in 92% of cases, the treatment prescription was made by the oncologist. HaH physicians were more involved in clinical assessment the day before treatment (19% vs. 0%), treatment validation (56% vs. 15%), and treatment prescription (19% vs. 0%), while nurses were better equipped (emergency kit available in 81% versus 50% of cases) when HaHs did carry out ICIs compared to when they did not. Most oncologists agreed that age, neuropsychiatric disorders, home environment, as well as treatment duration and good tolerance should be considered in patient selection. ECOG PS status and treatment response were less consensually considered. CONCLUSION: These results highlight the variability in French HaH organizations and patient selection criteria for employing ICIs at home. This study resulted in recommendations for administrating ICIs in HaH settings, which will likely be instrumental in further promoting this activity across France.
Asunto(s)
Servicios de Atención a Domicilio Provisto por Hospital/organización & administración , Inhibidores de Puntos de Control Inmunológico/administración & dosificación , Neoplasias/terapia , Factores de Edad , Francia , Servicios de Atención a Domicilio Provisto por Hospital/estadística & datos numéricos , Ambiente en el Hogar , Hospitalización , Humanos , Trastornos Mentales , Modelos Organizacionales , Enfermeras y Enfermeros , Oncólogos/estadística & datos numéricos , Selección de Paciente , Encuestas y Cuestionarios/estadística & datos numéricosRESUMEN
Like any disaster, the COVID-19 pandemic has presented significant challenges to healthcare systems, especially the threat of insufficient bed capacity and resources. Hospitals have been required to plan for and implement innovative approaches to expand hospital inpatient and intensive care capacity. This article presents how one of the largest healthcare systems in the United States leveraged existing technology infrastructure to create a virtual hospital that extended care beyond the walls of the "brick and mortar" hospital.
Asunto(s)
COVID-19 , Atención a la Salud/organización & administración , Servicios de Atención a Domicilio Provisto por Hospital/organización & administración , Hospitales , Capacidad de Reacción/organización & administración , Telemedicina/organización & administración , Humanos , Calidad de la Atención de Salud , SARS-CoV-2 , Telemedicina/métodos , Estados Unidos/epidemiologíaRESUMEN
BACKGROUND: Although home-based pulmonary rehabilitation programs have been shown in some studies to be an alternative and effective model, there is a lack of consensus in the medical literature due to different study designs and lack of standardization among procedures. Therefore, the purpose of this study was to compare the efficacy of a home-based versus outpatient pulmonary rehabilitation program for patients with chronic obstructive pulmonary disease (COPD). METHODS: Five electronic databases including Embase, PubMed, Scopus, Science Direct, and Cochrane Library will be searched in May 2021 by 2 independent reviewers. The reference lists of the included studies will be also checked for additional studies that are not identified with the database search. There is no restriction on the dates of publication or language in the search. The randomized controlled trials focusing on comparing home-based and outpatient pulmonary rehabilitation for COPD patients will be included in our meta-analysis. The following outcomes should have been measured: functional exercise capacity, disease-specific health-related quality of life, and cost-effectiveness measures. Risk ratio with a 95% confidence interval or standardized mean difference with 95% CI is assessed for dichotomous outcomes or continuous outcomes, respectively. RESULTS: It was hypothesized that these 2 methods would provide similar therapeutic benefits. REGISTRATION NUMBER: 10.17605/OSF.IO/5CV48.
Asunto(s)
Atención Ambulatoria/organización & administración , Servicios de Atención a Domicilio Provisto por Hospital/organización & administración , Enfermedad Pulmonar Obstructiva Crónica/rehabilitación , Calidad de Vida , Atención Ambulatoria/economía , Atención Ambulatoria/métodos , Análisis Costo-Beneficio , Tolerancia al Ejercicio , Servicios de Atención a Domicilio Provisto por Hospital/economía , Humanos , Metaanálisis como Asunto , Enfermedad Pulmonar Obstructiva Crónica/diagnóstico , Enfermedad Pulmonar Obstructiva Crónica/economía , Enfermedad Pulmonar Obstructiva Crónica/psicología , Ensayos Clínicos Controlados Aleatorios como Asunto , Revisiones Sistemáticas como Asunto , Resultado del TratamientoRESUMEN
ABSTRACT: Palliative care has improved quality of end-of-life (EOL) care for patients with cancer, and these benefits may be extended to patients with other serious illnesses. EOL care quality for patients with home-based care is a critical problem for health care providers. We compare EOL quality care between patients with advanced illnesses receiving home-based care with and without palliative services.The medical records of deceased patients who received home-based care at a community teaching hospital in south Taiwan from January to December 2019 were collected retrospectively. We analyzed EOL care quality indicators during the last month of life.A total of 164 patients were included for analysis. Fifty-two (31.7%) received palliative services (HP group), and 112 (68.3%) did not receive palliative services (non-HP group). Regarding the quality indicators of EOL care, we discovered that a lower percentage of the HP group died in a hospital than did that of the non-HP group (34.6% vs 62.5%, Pâ=â.001) through univariate analysis. We found that the HP group had lower scores on the aggressiveness of EOL care than did the non-HP group (0.5â±â0.9 vs 1.0â±â1.0, P<.001). Furthermore, palliative services were a significant and negative factor of dying in a hospital after adjustment (ORâ=â0.13, 95%CIâ=â0.05-0.36, Pâ<â.001).For patients with advanced illnesses receiving home-based care, palliative services are associated with lower scores on the aggressiveness of EOL care and a reduced probability of dying in a hospital.
Asunto(s)
Enfermedad Crítica/terapia , Servicios de Atención a Domicilio Provisto por Hospital/organización & administración , Cuidados Paliativos/organización & administración , Indicadores de Calidad de la Atención de Salud/estadística & datos numéricos , Cuidado Terminal/organización & administración , Anciano , Anciano de 80 o más Años , Enfermedad Crítica/mortalidad , Femenino , Servicios de Atención a Domicilio Provisto por Hospital/estadística & datos numéricos , Mortalidad Hospitalaria , Hospitales Comunitarios/organización & administración , Hospitales Comunitarios/estadística & datos numéricos , Hospitales de Enseñanza/organización & administración , Hospitales de Enseñanza/estadística & datos numéricos , Humanos , Masculino , Registros Médicos/estadística & datos numéricos , Cuidados Paliativos/métodos , Cuidados Paliativos/estadística & datos numéricos , Estudios Retrospectivos , Taiwán/epidemiología , Cuidado Terminal/métodos , Cuidado Terminal/estadística & datos numéricosRESUMEN
Approximately one-fifth to one-third of patients with adolescent anorexia nervosa (AN) need intensive care in the course of their illness. This article provides an update and discussion on different levels of intensive care (inpatient treatment (IP), day patient treatment (DP) and home treatment (HoT)) in different health care systems based on recently published literature. Important issues discussed in this article are new recommendations for the refeeding process and the definition of target weight as well as principles of medical stabilization and psychotherapeutic approaches. The pros and cons of longer or shorter hospitalization times are discussed, and the advantages of stepped care and day patient treatment are described. A new promising intensive treatment method involving the patient, their caregivers and the direct home environment is introduced. Parents and caregivers should be included in treatment research to foster collaborative work with the attending clinicians. There is an urgent need to evaluate the mid- to long-term outcomes of various intensive treatment programs to compare their effectiveness and costs across different health care systems. This could help policy makers and other stakeholders, such as public and private insurances, to enhance the quality of eating disorder care.
Asunto(s)
Servicios de Salud del Adolescente/organización & administración , Anorexia Nerviosa/terapia , Cuidados Críticos/métodos , Apoyo Nutricional/métodos , Psicoterapia/métodos , Adolescente , Atención Ambulatoria/métodos , Atención Ambulatoria/organización & administración , Anorexia Nerviosa/mortalidad , Anorexia Nerviosa/psicología , Índice de Masa Corporal , Cuidadores , Cuidados Críticos/organización & administración , Política de Salud , Servicios de Atención a Domicilio Provisto por Hospital/organización & administración , Hospitalización , Humanos , Padres , Calidad de la Atención de Salud , Participación de los Interesados , Resultado del TratamientoRESUMEN
BACKGROUND: The COVID-19 outbreak has posed considerable challenges to the health care system worldwide, especially for cancer treatment. We described the activity and the care organisation of the Hospitalisation At Home (HAH) structure during the pandemic for treating patients with anti-cancer injections. METHODS: We report the established organisation, the eligibility criteria, the patient characteristics, the treatment schemes and the stakeholders' role during two 5-week periods in 2020, before and during the French population's lockdown. RESULTS: The increase of activity during the lockdown (+32% of treated patients, +156% of new patients and +28% of delivered preparations) concerned solid tumour, mainly breast cancer, even if haematological malignancies remained the most frequent. Thirty different drugs were delivered, including three new drugs administered in HAH versus 19 during the routine period (p < 0.01). For those clinical departments accustomed to using HAH, the usual organisation was kept, but with adjustments. Five clinical departments increased the number of patients treated at home and widened the panel of drugs prescribed. Three oncology departments and one radiotherapy department for the first time solicited HAH for anti-cancer injections, mainly for immunotherapy. We adjusted the HAH organisation with additional human resources and allowed to prescribe drugs with an infusion time of <30 min only for the new prescribers. CONCLUSION: HAH allowed for the continuation of anti-cancer injections without postponement during the pandemic, and for a decrease in unnecessary patient travel to hospital with its concomitant COVID-19 transmission risk. Often left out of guidelines, the place of HAH in treating cancer patients should be reappraised, even more so during a pandemic.
Asunto(s)
Antineoplásicos/administración & dosificación , COVID-19/prevención & control , Servicios de Atención a Domicilio Provisto por Hospital/estadística & datos numéricos , Neoplasias/tratamiento farmacológico , SARS-CoV-2/aislamiento & purificación , Anciano , COVID-19/epidemiología , COVID-19/virología , Niño , Preescolar , Brotes de Enfermedades , Femenino , Francia , Servicios de Atención a Domicilio Provisto por Hospital/organización & administración , Humanos , Masculino , Oncología Médica/métodos , Oncología Médica/estadística & datos numéricos , Persona de Mediana Edad , Pandemias , Salud Pública/métodos , Salud Pública/estadística & datos numéricos , SARS-CoV-2/fisiologíaRESUMEN
OBJECTIVE: To evaluate the implementation of home telemonitoring and oxygen therapy in COVID-19 patients. Primary outcomes were safety, patient satisfaction, reduction of hospital stay, and cost-effectiveness. DESIGN: Retrospective cohort study. METHOD: All COVID-19 patients who were discharged with home telemonitoring and oxygen therapy between June 1st and November 1st 2020 were included. Eligible patients had a maximum oxygen requirement of 2 liters per minute during the 24 hours prior to discharge with a minimal peripheral oxygen saturation of 94%. A mobile application for telemonitoring was used, which patients or relatives had to be able to use independently. Patient demographics, clinical parameters, data on telemonitoring and readmissions were extracted from the electronic patient records. A survey for patient satisfaction and a cost-effectiveness analysis were performed. RESULTS: Out of 619 admissions, 49 patients were discharged with home telemonitoring and oxygen therapy. Median duration of home oxygen therapy was 11 days with a potential reduction in hospitalization of 616 days. Six patients were readmitted and were significantly more febrile on discharge (67% versus 14%, p=0.01) and had lower oxygenation (95%, (IQR 93-96) versus 96%, (IQR 95-97), p=0.02) with similar levels of oxygen administration. Patient satisfaction was high with a mean score of 5 to 6 on a scale measuring satisfaction from 1 to 7. Estimated total cost reduction was 146.736. CONCLUSION: This study shows that home telemonitoring and oxygen administration can be safely applied in COVID-19 patients resulting in a high patient satisfaction and reduction in hospital stay and costs.
Asunto(s)
COVID-19 , Servicios de Atención a Domicilio Provisto por Hospital/organización & administración , Tiempo de Internación , Monitoreo Fisiológico/métodos , Terapia por Inhalación de Oxígeno/métodos , Telemedicina , COVID-19/diagnóstico , COVID-19/epidemiología , COVID-19/rehabilitación , COVID-19/terapia , Análisis Costo-Beneficio , Determinación de la Elegibilidad , Femenino , Humanos , Tiempo de Internación/economía , Tiempo de Internación/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Países Bajos/epidemiología , Alta del Paciente , Seguridad del Paciente , Satisfacción del Paciente , Estudios Retrospectivos , SARS-CoV-2/aislamiento & purificación , Telemedicina/economía , Telemedicina/métodosRESUMEN
BACKGROUND/OBJECTIVES: COVID-19 required rapid innovation throughout the healthcare system. Home-based primary care (HBPC) practices faced unique challenges maintaining services for medically complex older populations for whom they needed to adapt a traditionally hands-on, model of care to accommodate restrictions on in-person contact. Our aim was to determine strategies used by New York City (NYC)-area HBPC practices to provide patient care during the first wave of the COVID-19 pandemic with the goal of informing planning and preparation for home-based practices nationwide. DESIGN: Cross-sectional qualitative design using semi-structured interviews. SETTING: HBPC practices in the NYC metro area during spring 2020. PARTICIPANTS: HBPC leadership including clinical/medical directors, program managers, nurse practitioners/nursing coordinators, and social workers/social work coordinators (n = 13) at 6 NYC-area practices. MEASUREMENTS: Semi-structured interviews explored HBPC practices' COVID-19 care delivery challenges, adaptations, and advice for providers. Interviewers probed patient care, end-of-life care, telehealth, community-based services and staffing. Interviews were recorded and transcribed. Data were analyzed through a combined inductive and deductive thematic approach. RESULTS: Participants described care delivery and operational adaptations similar to those universally adopted across healthcare settings during COVID-19, such as patient outreach and telehealth. HBPC-specific adaptations included mental health services for patients experiencing depression and isolation, using multiple modalities of patient interactions to balance virtual care with necessary in-person contact, strategies to maintain patient trust, and supporting team connection of staff through daily huddles and emotional support during the surge of deaths among long-standing patients. CONCLUSION: NYC-area HBPC providers adapted care delivery and operations rapidly during the height of the COVID-19 pandemic. Keeping older, medically complex patients safe in their homes required considerable flexibility, transparency, teamwork, and partnerships with outside providers. As the pandemic continues to surge around the United States, HBPC providers may apply these lessons and consider resources needed to prepare for future challenges.
Asunto(s)
COVID-19/terapia , Implementación de Plan de Salud/estadística & datos numéricos , Servicios de Atención a Domicilio Provisto por Hospital/organización & administración , Personas Imposibilitadas/rehabilitación , Atención Primaria de Salud/organización & administración , Anciano , COVID-19/epidemiología , Estudios Transversales , Femenino , Humanos , Ciudad de Nueva York , Evaluación de Procesos y Resultados en Atención de Salud , Grupo de Atención al Paciente , Investigación Cualitativa , Estados UnidosRESUMEN
In Italy, SARS-CoV-2 outbreak registered a high transmission and disease rates. During the acute phase, oncologists provided to re-organize services and prioritize treatments, in order to limit viral spread and to protect cancer patients. The progressive reduction of the number of infections has prompted Italian government to gradually loosen the national confinement measures and to start the "Second phase" of measures to contain the pandemic. The issue on how to organize cancer care during this post-acute SARS-CoV-2 phase appears crucial and a reassessment of healthcare services is needed requiring new models of care for oncological patients. In order to address major challenges in cancer setting during post-acute SARS-CoV-2 phase, this work offers multidimensional solutions aimed to provide a new way to take care of cancer patients.
Asunto(s)
Control de Enfermedades Transmisibles/organización & administración , Infecciones por Coronavirus/prevención & control , Oncología Médica/organización & administración , Modelos Organizacionales , Neoplasias/terapia , Pandemias/prevención & control , Neumonía Viral/prevención & control , Betacoronavirus/patogenicidad , COVID-19 , Prueba de COVID-19 , Técnicas de Laboratorio Clínico/normas , Control de Enfermedades Transmisibles/normas , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/transmisión , Servicios de Atención a Domicilio Provisto por Hospital/organización & administración , Servicios de Atención a Domicilio Provisto por Hospital/normas , Humanos , Italia/epidemiología , Oncología Médica/normas , Neoplasias/diagnóstico , Neumonía Viral/diagnóstico , Neumonía Viral/epidemiología , Neumonía Viral/transmisión , SARS-CoV-2 , Triaje/organización & administración , Triaje/normasRESUMEN
We describe the expansion and adaptation of a frailty response team to assess older people in their usual place of residence. The team had commenced a weekend service to a limited area in February 2020. As a consequence of demand related to the COVID-19 pandemic, we expanded it and adapted the model of care to provide a 7-day service to our entire catchment area. Five hundred and ninety two patient reviews have been completed in the first 105 days of operation with 43 patients transferred to hospital for further investigation or management following assessment.
Asunto(s)
Infecciones por Coronavirus/epidemiología , Servicios Médicos de Urgencia/organización & administración , Anciano Frágil , Evaluación Geriátrica , Servicios de Salud para Ancianos/organización & administración , Servicios de Atención a Domicilio Provisto por Hospital/organización & administración , Neumonía Viral/epidemiología , Anciano , Anciano de 80 o más Años , Betacoronavirus , COVID-19 , Femenino , Humanos , Irlanda/epidemiología , Masculino , Pandemias , SARS-CoV-2Asunto(s)
Control de Enfermedades Transmisibles/organización & administración , Infecciones por Coronavirus/prevención & control , Atención a la Salud/organización & administración , Servicios de Atención a Domicilio Provisto por Hospital/organización & administración , Pandemias/prevención & control , Neumonía Viral/prevención & control , COVID-19 , China/epidemiología , Infecciones por Coronavirus/epidemiología , Femenino , Humanos , Masculino , Pandemias/estadística & datos numéricos , Neumonía Viral/epidemiología , Formulación de Políticas , Desarrollo de Programa , Evaluación de Programas y Proyectos de SaludRESUMEN
BACKGROUND: A metropolitan-based baccalaureate nursing program (N = 350) faced multiple challenges regarding maximizing students' clinical time. The Home Hospital option allowed students' clinical rotations to remain at the same agency throughout the nursing program versus rotating to multiple sites. METHOD: A 3.5-year quality improvement study surveyed a convenience sample of students (n = 210) regarding benefits and limitations of the Home Hospital option including ease of on-boarding, appreciation by staff, opportunity to learn agencies' culture, and overall satisfaction. Data were extrapolated from an online program exit survey. RESULTS: More than 90% of students stated they would repeat the experience and recommend the Home Hospital option to future students. CONCLUSION: Offering a Home Hospital option for student placements provided many benefits and a possible solution to deal with the complexities of maximizing clinical experiences. Academic partnerships should continue to evolve especially where there is a scarcity of placement options. [J Nurs Educ. 2020;59(5):269-273.].
Asunto(s)
Bachillerato en Enfermería/organización & administración , Servicios de Atención a Domicilio Provisto por Hospital/organización & administración , Adulto , Actitud del Personal de Salud , Femenino , Humanos , Masculino , Persona de Mediana Edad , Investigación en Educación de Enfermería , Estudiantes de Enfermería/psicología , Encuestas y Cuestionarios , Adulto JovenRESUMEN
OBJECTIVE: To describe uptake of hospital in the home (HIH) by major Australian hospitals and the characteristics of patients and their HIH admissions; to assess change in HIH admission numbers relative to total hospital activity. DESIGN: Descriptive, retrospective study of HIH activity, analysing previously collected census data for all multi-day hospital inpatient admissions to included hospitals during the period 1 January 2011 - 31 December 2017. SETTING, PARTICIPANTS: Nineteen principal referrer hospital members of the Health Roundtable in Australia. MAIN OUTCOME MEASURES: HIH admissions by diagnosis-related group (DRG); patient and admission characteristics. RESULTS: 80 167 of 2 185 421 admissions to the 19 hospitals included HIH care, or 3.7% (95% CI, 3.6-3.7%) of all admissions. Median length of stay for admissions including HIH (7.3 days; IQR, 3.1-14 days) was longer than that for those that did not (2.7 days; IQR, 1.6-5.1 days). For HIH admissions, the proportion of men was higher (54.4% v 45.9%), the proportion of patients who died in hospital was lower (0.3% v 1.4%), and re-admission within 28 days was less frequent (2.3% v 3.6%). The 50 DRGs with greatest HIH activity encompassed 65 811 HIH admissions (82.1%), or 8.4% (95% CI, 8.4-8.5%) of all admissions in these DRGs. HIH admission numbers grew more rapidly than non-HIH admissions, but the difference was not statistically significant. CONCLUSIONS: HIH care is most frequently provided to patients requiring hospital treatment related to infections, venous thromboembolism, or post-surgical care. Its use could be expanded in clinical areas where it is currently used, and extended to others where it is not. HIH activity is growing. It should be systematically monitored and reported to allow better overview of its use and outcomes.